Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients
Dirk Arnold(Asklepios Klinik Altona), Siraj Misbah(Churchill Hospital), Raashid Luqmani(Nuffield Orthopaedic Centre), Andrew E. Timms
Cited by 33
Related Papers
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
|Annals of the Rheumatic Diseases|2019|1.1k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k
EULAR recommendations for the management of primary small and medium vessel vasculitis
|Annals of the Rheumatic Diseases|2008|986